Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A-Reference-Cited by-同舟云学术

Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A

Published:2013-04 Issue:4 Volume:11 Page:670-678
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Tiede A.¹,Brand B.²,Fischer R.³,Kavakli K.⁴,Lentz S. R.⁵,Matsushita T.⁶,Rea C.⁷,Knobe K.⁸,Viuff D.⁸

Affiliation:

1. Hannover Medical School; Hannover Germany

2. University Hospital Zurich; Zurich Switzerland

3. Universitätsklinikum Gießen and Marburg; Gießen Germany

4. Ege University Children's Hospital; Izmir Turkey

5. Carver College of Medicine; The University of Iowa; Iowa City IA USA

6. Nagoya University Hospital; Nagoya Aichi Japan

7. St Thomas' Hospital; London UK

8. Novo Nordisk A/S; Søborg Denmark

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12161/fullpdf

Reference25 articles.

1. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia;Manco-Johnson;N Engl J Med,2007

2. Prophylaxis in the haemophilia population;Blanchette;Haemophilia,2010

3. Haemophilia prophylaxis in young patients - a long-term follow-up;Löfqvist;J Intern Med,1997

4. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B;Nilsson;J Intern Med,1992

5. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A;Collins;J Thromb Haemost,2009

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-9 methylated caffeine: An alternate potentially active pharmaceutical ingredient to caffeine and its complexation with β-CD;Journal of Molecular Structure;2024-09

2. Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life;Bleeding, Thrombosis and Vascular Biology;2024-04-22

3. Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review;Haemophilia;2024-03-29

4. Pegylation, a Successful Strategy to Address the Storage and Instability Problems of Blood Products: Review 2011-2021;Current Pharmaceutical Biotechnology;2024-02

5. Shifting Paradigms and Arising Concerns in Severe Hemophilia A Treatment;Seminars in Thrombosis and Hemostasis;2024-01-15